What was the number of opioid-related deaths in the United States (US) in 2017?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Opioid-Related Deaths in the United States in 2017

In 2017, there were 47,600 opioid-involved overdose deaths in the United States, representing approximately two-thirds of all drug overdose deaths (70,237) that year. 1

Epidemiological Context

The opioid crisis in 2017 represented a critical point in the ongoing epidemic:

  • The total number of drug overdose deaths (70,237) represented a 21.4% increase from 2015 2
  • The national age-adjusted death rate from drug overdoses had more than tripled from 6.1 per 100,000 people in 1999 to 21.6 per 100,000 people in 2019 3
  • Significant geographic variation existed across states, with highest overdose death rates in:
    • West Virginia (51.5 per 100,000)
    • Delaware (43.8 per 100,000)
    • Maryland (37.2 per 100,000)
    • Pennsylvania (36.1 per 100,000)
    • Ohio (35.9 per 100,000)
    • New Hampshire (35.8 per 100,000) 3

Breakdown by Opioid Type

The 2017 opioid death toll reflected the evolution of the epidemic:

  • Deaths involving synthetic opioids (primarily illicitly manufactured fentanyl) showed the most dramatic increase, rising 80% between 2013 and 2014 4
  • Heroin-involved deaths increased 26% between 2013 and 2014 4
  • Natural and semisynthetic opioid deaths (prescription painkillers) increased 9% between 2013 and 2014 4

Demographic Impact

The epidemic most severely affected adults aged 25-54 years 5:

  • 25-34 years: 38.4 per 100,000
  • 35-44 years: 39.0 per 100,000
  • 45-54 years: 37.7 per 100,000 3

Contributing Factors

Several factors contributed to the high mortality rate in 2017:

  • Increased availability of illicitly manufactured fentanyl and fentanyl analogs 2
  • Polysubstance use, with 62.6% of opioid deaths co-occurring with at least one common non-opioid drug 6
  • Concurrent benzodiazepine use, found in 31-61% of opioid overdose decedents 5
  • Methadone disproportionately associated with overdose deaths relative to prescribing frequency 5

Public Health Impact

The opioid crisis has had profound effects on public health:

  • Contributed significantly to decreasing life expectancy in the United States 5
  • Drug-related deaths surpassed motor vehicle crashes as the leading cause of injury-related death in adults 3
  • For individuals aged 24-35 years, opioids caused 20% of deaths 3
  • The epidemic worsened during the COVID-19 pandemic, with increases in opioid-related mortality in over 40 states 3

Historical Context

The 2017 data represents a critical point in the epidemic that had been developing in distinct phases:

  • Initial phase with aggressive pharmaceutical marketing and changing prescribing practices
  • Prescription opioid phase
  • Heroin phase
  • Synthetic opioid phase (particularly fentanyl) 5

The 2017 death toll of 47,600 opioid-related deaths represents one of the highest points in the epidemic, with provisional data from 2018 suggesting a potential small decrease in the following year 1.

References

Research

Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.

MMWR. Morbidity and mortality weekly report, 2020

Research

Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.

MMWR. Morbidity and mortality weekly report, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014.

MMWR. Morbidity and mortality weekly report, 2016

Guideline

Opioid-Involved Overdose Deaths

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.